SCHEMBL5793136

SCHEMBL5793136

CCCCC(N)c1ccccc1NCc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.42
PLK1 P53350 1/20 0.42
BACE1 P56817 1/20 0.41
CASP6 P55212 1/20 0.40
TSHR P16473 2/20 0.40
KDM4E B2RXH2 1/20 0.40
HPGD P15428 1/20 0.40
L3MBTL1 Q9Y468 3/20 0.39
GRM2 Q14416 1/20 0.39
CSNK1E P49674 1/20 0.38
CNR2 P34972 1/20 0.38
PDE4B Q07343 2/20 0.38
PDE4A P27815 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
PDE3B Q13370 1/20 0.38
PDE3A Q14432 1/20 0.38
CDK1 P06493 1/20 0.38
CDK5 Q00535 1/20 0.38
ALDH1A1 P00352 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14686239 0.74 HSD17B10 (0.50) HSD17B10BACE1TSHRKDM4EHPGD
SCHEMBL12859084 0.74 HSD17B10 (0.53) HSD17B10BACE1TSHRKDM4EHPGD
SCHEMBL17468739 0.73 HSD17B10 (0.49) HSD17B10BACE1TSHRKDM4EHPGD
SCHEMBL10490374 0.71 HSD17B10 (0.50) HSD17B10BACE1TSHRKDM4EHPGD
SCHEMBL1537231 0.71 CYP1A2 (0.43) HSD17B10KDM4ECSNK1ECNR2ALDH1A1
SCHEMBL26999631 0.71 ESR1 (0.41) CSNK1E
SCHEMBL28864994 0.70 HSD17B10 (0.49) HSD17B10BACE1TSHRKDM4EHPGD
SCHEMBL5792353 0.69 TSHR (0.50) TSHRKDM4ECSNK1ECNR2ALDH1A1
SCHEMBL1727508 0.69 IDO1 (0.39) L3MBTL1CSNK1EALDH1A1LMNA
SCHEMBL1728815 0.69 IDO1 (0.39) L3MBTL1CSNK1EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060079696-A1 Substituted compounds derived from N-(benzyl)phenylacetamide, preparation and uses GENFIT (FR) 2006-04-13 US disclosed
WO-2006035157-A2 SUBSTITUTED N-(BENZYL)PHENYLACETAMIDE DERIVATIVE COMPOUNDS, PREPARATION METHOD THEREOF AND USES OF SAME AS PPAR LIGANDS IN THE TREATMENT OF LIPID AND/OR GLUCIDIC DISORDERS GENFIT (FR) 2006-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060079696-A1 Substituted compounds derived from N-(benzyl)phenylacetamide, preparation and uses AADAC, NAT1, PARN HSD17B10 3633/4885PLK1 3401/4885BACE1 4200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.